Search results
Jardiance vs. Farxiga: Similarities and Differences
Verywell Health via Yahoo News· 2 months agoLearn more about the similarities and differences between Jardiance (empagliflozin) and Farxiga (dapagliflozin), two SGLT2 inhibitors used for treating...
AstraZeneca's Farxiga cuts death risk in heart failure patients -study
Reuters via Yahoo News· 2 years agoAstraZeneca's blockbuster diabetes drug Farxiga led to significant reductions in the risk of...
FDA Expands Lilly (LLY) Jardiance Label in Chronic Kidney Disease
Zacks via Yahoo Finance· 7 months agoEli Lilly LLY announced that the FDA has expanded the label of its diabetes drug, Jardiance...
Lilly (LLY) Jardiance Kidney Disease sNDA Gets FDA Acceptance
Zacks via Yahoo Finance· 1 year agoEli Lilly's (LLY) sNDA seeks approval for diabetes medicine, Jardiance, to reduce the risk of kidney...
Pharma Stock Roundup: FDA and EMA Regulatory Updates for ABBV, LLY, SNY & MRK's Drugs
Zacks via Yahoo Finance· 7 months agoThis week, the European Commission granted marketing approval to AbbVie’s ABBV Tepkinly...
Long-Term Beta-Blocker Use May Not Benefit Certain Patients, Studies Find
Verywell Health via Yahoo News· 10 months agoBeta-blockers are a tried-and-true class of medications prescribed to patients who have experienced...
What Is Heart Disease?
Verywell Health via Yahoo News· 12 months agoAlso Known as Cardiovascular Disease (CVD) Suriyapong Thongsawang / Getty Images Medically reviewed by Jeffrey S. Lander, MD "Heart disease," or...
Could This New Drug Indication Be a Winner for Eli Lilly?
Motley Fool· 1 year agoEli Lilly (NYSE: LLY) and Boehringer Ingelheim's supplemental New Drug Application for Jardiance...
Medicare can now negotiate prices on these drugs to help seniors save
Newsy via AOL· 8 months agoThe exterior of Pfizer in Groton, Conn. The Biden administration announced the first 10 drugs...
U.S. FDA approves Lexicon Pharma's drug for heart failure
Reuters via Yahoo News· 11 months ago(Reuters) -The U.S. Food and Drug Administration (FDA) has approved Lexicon Pharmaceuticals Inc's...